Determinants of Allergic Sensitization, Asthma and Lung Function: Results from a Cross-Sectional Study in Italian

Gaspare Drago1, Silvia Ruggieri1, Giuseppina Cuttitta1

  • 1National Research Council of Italy, Institute for Biomedical Research and Innovation, 90146 Palermo, Italy.

Insights

Maternal smoking during pregnancy and early respiratory infections significantly increase childhood asthma risk. Early respiratory diseases, influenced by prenatal smoke exposure, strongly impact childhood asthma and lung function, especially in males.

Area of Science:

  • Pediatrics
  • Environmental Health
  • Respiratory Medicine

Background:

  • Childhood asthma is influenced by prenatal smoke exposure and early respiratory infections.
  • Understanding the interplay of individual and environmental factors is crucial for managing pediatric respiratory health.

Purpose of the Study:

  • To investigate factors influencing allergic sensitization, asthma, and lung function in children.
  • To examine the roles of maternal smoking during pregnancy and early respiratory diseases.

Main Methods:

  • A study of 1714 children (aged 7-16) in southern Italy.
  • Utilized parental questionnaires, skin prick tests, and spirometry.
  • Analyzed risk factors for allergic sensitization, asthma, and lung function.

Main Results:

  • 41.0% prevalence of allergic sensitization.
  • Maternal smoking during pregnancy and early respiratory diseases were key risk factors for allergic sensitization and asthma.
  • Early respiratory diseases significantly impaired lung function (FEF25-75%), particularly in males exposed to maternal smoking.

Conclusions:

  • Early respiratory diseases, influenced by prenatal smoke exposure, are critical determinants of childhood asthma and lung function.
  • Interventions targeting prenatal smoke exposure and early respiratory infections may mitigate pediatric asthma development.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.2K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Allergic Reactions02:06

Allergic Reactions

Overview
31.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K